Recombinant Human CD23 Protein，His

CD23, also known as the low-affinity IgE receptor, is a type II membrane protein that plays a crucial role in regulating IgE production and maintaining immune homeostasis. Discovered on the surface of B cells and activated monocytes, CD23 functions as a receptor for IgE and plays a key role in allergenic responses, as well as in the maturation and activation of B cells. Its involvement in various immune processes makes it a significant target for research, particularly in understanding allergic diseases, asthma, and certain types of cancer. The recombinant CD23 protein has been instrumental in elucidating its biochemical properties and functional mechanisms. Studies have shown that CD23 modulates the immune response through its interactions with IgE, contributing to the differentiation of B cells and the secretion of cytokines. This has led to further exploration of its potential as a therapeutic target, particularly in conditions characterized by dysregulated IgE responses. The ability to produce recombinant CD23 has facilitated investigations into its structure-function relationships and the development of novel immunomodulatory therapies. Understanding the role of CD23 at the molecular level may provide insights into innovative treatments for allergic diseases, thereby offering new avenues for improving patient care and outcomes. The ongoing research on CD23 and its recombinant forms is crucial for designing effective interventions targeting IgE-mediated conditions and advancing our knowledge of immune regulation.